Akers Logo Top Akers Biosciences  
Akers Logo Bottom
 
 
 
home > investor relations > investor faq
Investor Relations - Investor FAQ
When was Akers Biosciences initial public offering and what was the offering price?
Akers went public on May 22, 2002 at a U.S. equivalent price of $2.00 per share.

Who is Akers Biosciences' transfer agent?
Capita Registrars
34 Beckenham Road
Kent, UK
BR3 4TU
44 20 8639 2157
http://www.capitaregistrars.com

What stock exchange is Akers Biosciences listed on?
Akers Biosciences is listed on the London Stock Exchange under the ticker symbol AKR.

How can I get a history of Akers Biosciences' closing stock prices?
To review the latest prices and news, go to www.londonstockexchange.com. For historical prices, go to http://finance.yahoo.com.

I would like to buy shares of Akers Biosciences. Can I make direct purchases from the company?
No. Currently, Akers Biosciences does not have a direct purchase program available.

Has Akers Biosciences ever had any stock splits?
No, Akers Biosciences has not had a stock split since going public.

How do I get a copy of the current Akers Biosciences' annual report?

Current and past annual reports are available online.  Please access this information in the Annual Reports & Admission Documents section of this website.


How do I find upcoming events?
Please contact our USA Corporate Headquarters by calling +1 856.848.2116 .

How do I contact Investor Relations?
Please contact Ben Simons at M Communications Limited by calling +44(0)20 7153 1530 or sending an email to simons@mcomgroup.com.


   

© 2009 Akers Biosciences, Inc. All Rights Reserved.
Technical Services